Weight Loss Injections in Saskatchewan: SK Drug Plan & Access Guide

Saskatchewan is home to approximately 1.2 million residents. The Saskatchewan Drug Plan provides prescription drug coverage to eligible residents, with Ozempic listed on the formulary for type 2 diabetes under a special authorization process. Like most provinces, there is no provincial coverage for GLP-1 medications prescribed solely for weight management.

Saskatchewan at a Glance

Saskatchewan Drug Plan Coverage

The Saskatchewan Drug Plan (SK Drug Plan) provides prescription drug coverage to eligible Saskatchewan residents. Coverage is provided to seniors (65+), residents on social assistance, and those with certain disabilities. Ozempic (semaglutide) is listed on the SK Drug Plan formulary under special authorization for type 2 diabetes.

Special authorization criteria for Ozempic under the SK Drug Plan generally require:

• Confirmed diagnosis of type 2 diabetes mellitus
• HbA1c above target (typically ≥ 7.0%) despite other antihyperglycemic therapy
• Documented prior use of metformin (or contraindication to it)
• No absolute contraindications to semaglutide

Working-age Saskatchewanians who are employed and not on social assistance typically rely on employer group benefits for drug coverage. The SK Drug Plan is primarily for seniors and socially assisted residents.

Wegovy in Saskatchewan

Wegovy is not listed on the SK Drug Plan formulary for weight management. Private employer benefits or out-of-pocket payment are the primary options for Saskatchewanians seeking Wegovy.

Private Insurance in Saskatchewan

Saskatchewan's economy includes significant agricultural, resource (potash, oil), and public sector employment - all sectors that often provide group drug benefits. GLP-1 coverage through private plans varies significantly by employer:

• Resource and energy sector employers (Mosaic, Nutrien, Saskatchewan Oil/Gas) typically have comprehensive benefit plans that may cover GLP-1s with prior authorization
• Provincial government employees covered under the Saskatchewan Government and General Employees' Union (SGEU) plan may have GLP-1 coverage with PA
• Smaller employers often have more limited formularies - check your specific benefits booklet

Getting a Prescription Online in Saskatchewan

Felix Health is available province-wide in Saskatchewan. The online assessment and prescription process is identical to other provinces - a Saskatchewan-licensed physician reviews your health intake and can prescribe GLP-1 medications if clinically appropriate, with delivery to any Saskatchewan address.

Cost in Saskatchewan Without Coverage

Without insurance in Saskatchewan, approximate monthly costs as of May 2026:

• Ozempic (0.5–2 mg): ~$225–$410/month
• Wegovy (2.4 mg): ~$395–$425/month
• Mounjaro (5–15 mg): ~$490–$610/month
• Generic semaglutide (expected 2025-26): Estimated $50–$150/month

See the full province-by-province cost guide for more detail.

Saskatchewan FAQ

Does the SK Drug Plan cover Ozempic for weight loss without diabetes?

No. The SK Drug Plan covers semaglutide for type 2 diabetes only. Weight management without a diabetes diagnosis is not a covered indication.

Is Felix available throughout Saskatchewan?

Yes. Felix Health operates province-wide in Saskatchewan and can prescribe GLP-1 medications and arrange delivery to any Saskatchewan address.